Halozyme expects $1.86B-$1.925B 2026 revenue while raising non-GAAP EPS to $8.75-$9.05
This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:
Read full article at Seeking Alpha
This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:
Read full article at Seeking Alpha